This webinar will cover a wide range of topics related to the investing in a healthcare startup and features an incredible member of the angel community, Dr. David Gershon.
Webinar objectives will be:
To increase awareness about how healthcare start-ups are driven by scientific breakthroughs to deliver better healthcare to patients.
To break down barriers that investors have to healthcare investment including understanding the technical/scientific complexities, regulations and IP.
To define the potential ROI in healthcare investing, while simultaneously mitigating risk.
Dr. David Martin Gershon is the Founder of Gershon Capital and the Managing Partner of the Endeavor Life Sciences Venture Fund I and II, investing in great entrepreneurs and life science companies that possess innovative technologies and strong commercial potential.
Dr. Gershon has 20 years of experience as a neuroscientist, oncologist/immunologist, healthcare economist, and FDA healthcare regulatory attorney, with expertise in drug and device approval processes, clinical research, and pricing and reimbursement.
Amongst his accomplishments Dr. Gershon is a Standard & Poor’s Healthcare Industry Leader, former Chairman of the Aspen Institute Business of Health Program, Aspen Institute Senior Fellow, and Memorial Sloan-Kettering Cancer Center Mayday Fellow and has been a Senior Advisor to McKinsey & Co., Goldman Sachs, Bain Capital, Texas Pacific Group, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, BlackRock, Caxton Associates, Pictet Group, Merrill Lynch, UBS, SG Cowen, Tiger Global, Fidelity Investments, the William J. Clinton Foundation, the Federal Reserve Board of Governors, and the Rockefeller Foundation.
Dr. Gershon has been featured as a leading expert in healthcare and life science investment on CNBC and has been a speaker at numerous conferences including the Harvard Business School Health Industry Alumni Conference, and is an Adjunct Professor of Healthcare Economics and Policy at Johns Hopkins University, Guest Lecturer of Healthcare Finance abd Drug Development at Harvard University and MIT Sloan Business School, Assistant Professor of Healthcare Economics and Finance at Columbia University, Visiting Scholar Lecturer of Healthcare Economics and Policy at McGill University, Advisor in Entrepreneurship to the NYU Stern School of Business, Berkeley Center for Entrepreneurial Studies, Columbia University School of Business, Eugene M. Lang Center for Entrepreneurship, and Harvard Innovation Labs.